Ignite Creation Date:
2024-05-05 @ 5:30 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00468650
Status:
COMPLETED
Last Update Posted:
2021-02-18
First Post:
2007-05-01
Brief Title:
A Multicenter Open Label To Evaluate The Efficacy And Satisfaction Of Patrex In Men With Erectile Dysfunction
Sponsor:
Pfizers Upjohn has merged with Mylan to form Viatris Inc
Organization:
Pfizer
Study Overview
Official Title:
A Multicenter Open Label High Dose 100mg Rapid Titration Study To Evaluate The Efficacy And Satisfaction Of Patrex Sildenafil Citrate In Men With Erectile Dysfunction In Mexico
Status:
COMPLETED
Status Verified Date:
2021-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A multicenter open label study to assess the efficacy of sildenafil rapid dose titration to 100 mg in men with erectile dysfunction based on the Erectile Function EF domain score of the International Index of Erectile Function IIEF questionnaire
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None